A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
Clinical trial NCT03292588 · COMPLETED
Trial details
- NCT number
- NCT03292588
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2021-04-20
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.